Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
10K
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
+2.64M
-
Total reported value, excl. options
-
$221M
-
Value change
-
+$13M
-
Put/Call ratio
-
6.08
-
Number of buys
-
60
-
Number of sells
-
-66
-
Price
-
$5.97
Significant Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q1 2025
160 filings reported holding ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q1 2025.
iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
.
Largest 10 shareholders include BlackRock, Inc. (4.51M shares), RA CAPITAL MANAGEMENT, L.P. (3.65M shares), BVF INC/IL (3.08M shares), MPM ASSET MANAGEMENT LLC (2.74M shares), TANG CAPITAL MANAGEMENT LLC (2.69M shares), JPMORGAN CHASE & CO (1.98M shares), 683 Capital Management, LLC (1.75M shares), MPM BIOIMPACT LLC (1.75M shares), VANGUARD GROUP INC (1.73M shares), and DIMENSIONAL FUND ADVISORS LP (1.18M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.